Novartis Oncology Director of Finance Salaries in Wilmington, DE | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Director of Finance Salaries in Wilmington, DE

The average Novartis Oncology Director of Finance in Wilmington, DE earns an estimated $144,091 annually. Novartis Oncology's Director of Finance compensation is $17,925 less than the US average for a Director of Finance.

In Wilmington, DE, The Finance Department at Novartis Oncology earns $16,348 more on average than the Admin Department.

Last updated 3 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$144,091
Average Compensation
$144,091
avg. base

Director of Finance Salaries at Novartis Oncology

In Wilmington, DE, Directors of Finance earn $25,189 more than Accounting Managers.

Accounting Manager
$119k*
Business Analyst
$94k*
Senior Accountant
$90k*
Financial Analyst
$71k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Wilmington, DE, The Finance Department averages $16,348 more than the Admin Department, and $12,531 less than the IT Department

IT
$95,606 Avg. total comp.
+$13k
Finance
$83,075 Avg. total comp.
Admin
$66,727 Avg. total comp.
-$16k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Novartis Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Novartis Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Novartis Oncology Rate Their Compensation

The majority of Directors of Finance at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Finance at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company